AlphaTime flags going-concern doubt, $4.49M deficit
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
AlphaTime Acquisition Corp. reported a $159,875 net loss for the three months ended March 31, 2026, versus $117,969 net income a year earlier. Formation and operating costs were $202,143, and Trust Account income was $42,268. Its proposed HCYC business combination remains uncompleted; the $11.5 million PIPE is expected to close substantially concurrently with, and is conditioned on, the combination.
At March 31, 2026, cash outside the Trust Account was $1,233, the Trust Account held $4,841,963, and the working capital deficit was $4,491,174. Management said the deficit and potential liquidation raise substantial doubt about going concern, and its plans do not alleviate that doubt. Disclosure controls were ineffective due to a material weakness in review of related-party transactions.
Shareholders authorized up to eight one-month extensions through December 4, 2026; each takes effect only after five days’ advance notice and a $15,000 deposit. $565,144 in extension payments was undeposited at March 31, leaving uncertainty about whether some extensions took effect and the business-combination deadline. Nasdaq delisted the securities; they are not listed on any national securities exchange.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- None.
Negative
- Major pointManagement said its plans did not alleviate going-concern doubt at March 31, 2026.
- Major pointRelated-party review weakness left disclosure controls ineffective at March 31, 2026.
- Major pointNasdaq delisting left ATMC securities unlisted on any national securities exchange.
- Moderate pointUndeposited extension payments totaled $565,144 at March 31, 2026. 1.7% of market cap
- Minor pointQuarterly earnings shifted from $117,969 income to a $159,875 loss.
Filing Explained
Neither the conditional PIPE issuance nor 382,091 elected redemptions has yet changed ownership because the combination remains unclosed.
The approved HCYC combination remains uncompleted, and the filing specifies that its conditional PIPE would issue 1,150,000 ordinary shares at
If the PIPE closes and the warrants are exercised, those additional shares would increase the share count and reduce existing holders’ percentage ownership. Separately, holders of 382,091 shares elected to redeem in connection with the combination, but those redemptions have not become effective and take effect only at closing.
Key Figures
Key Terms
working capital deficit financial
going concern financial
temporary equity financial
two-class method financial
deferred underwriting commission financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is the status of ATMC’s HCYC merger and PIPE financing?
What extensions did ATMC shareholders authorize?
Why were ATMC securities delisted from Nasdaq?
How much did ATMC pay shareholders who elected to redeem in April 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
For
the quarterly period ended
Or
For the transition period from to
Commission
File Number
(Exact name of registrant as specified in its charter)
| N/A
( | ||
(State or Other Jurisdiction of Incorporation) |
(I.R.S. Employer Identification No.) | |
| N/A | ||
| (Address of principal executive offices) | (zip code) |
(Issuer’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading Symbols | Name of Each Exchange on Which Registered | ||
| N/A | ||||
| N/A | ||||
| N/A | ||||
| N/A |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| ☒ | Smaller reporting company | ||
| Emerging growth company |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
As
of November 12, 2026, there were
TABLE OF CONTENTS
| Page | |||
| Part I. | Financial Information | F-1 | |
| Item 1. | Condensed Financial Statements | F-1 | |
| Condensed Balance Sheets as of March 31, 2026 (Unaudited) and December 31, 2025 | F-1 | ||
| Unaudited Condensed Statements of Operations for the three months ended March 31, 2026 and 2025 | F-2 | ||
| Unaudited Condensed Statements of Changes in Shareholders’ Equity/(Deficit) for the three months ended March 31, 2026 and 2025 | F-3 | ||
| Unaudited Condensed Statements of Cash Flows for the three months ended March 31, 2026 and 2025 | F-4 | ||
| Notes to Unaudited Condensed Financial Statements | F-5 | ||
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 1 | |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 4 | |
| Item 4. | Controls and Procedures | 4 | |
| Part II. | Other Information | 5 | |
| Item 1. | Legal Proceedings | 5 | |
| Item 1A. | Risk Factors | 5 | |
| Item 2. | Unregistered Sales of Equity Securities | 5 | |
| Item 5. | Other Information | 5 | |
| Item 6. | Exhibits | 6 | |
| Signatures | 7 | ||
| i |
PART I - FINANCIAL INFORMATION
ALPHATIME ACQUISITION CORP
CONDENSED BALANCE SHEETS
| March 31, 2026 | December 31, 2025 | |||||||
| Assets: | ||||||||
| Current assets: | ||||||||
| Cash | $ | $ | ||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Investment held in Trust Account | ||||||||
| Total assets | $ | |||||||
| Liabilities and Shareholders’ Deficit: | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued expenses | $ | $ | ||||||
| Promissory notes – related party | ||||||||
| Due to HCYC | ||||||||
| Due to related parties | ||||||||
| Total current liabilities | ||||||||
| Deferred underwriting commission | ||||||||
| Total liabilities | ||||||||
| Commitments and Contingencies | - | - | ||||||
| Temporary Equity: | ||||||||
| Ordinary shares subject to possible redemption, | ||||||||
| Shareholders’ Deficit: | ||||||||
| Preferred shares, $ | - | - | ||||||
| Ordinary Shares, $ | ||||||||
| Additional paid-in capital | - | - | ||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total Shareholders’ Deficit | ( | ) | ( | ) | ||||
| Total Liabilities, Temporary Equity and Shareholders’ Deficit | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| F-1 |
ALPHATIME ACQUISITION CORP
CONDENSED STATEMENTS OF OPERATIONS
For the three months ended March 31, 2026 and 2025 (Unaudited)
| 2026 | 2025 | |||||||
| Three months ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| Formation and operating costs | $ | $ | ||||||
| Total Expenses | $ | ( | ) | $ | ( | ) | ||
| Other income | ||||||||
| Income earned on Trust Account | ||||||||
| Net income (loss) | $ | ( | ) | $ | ||||
| Weighted average shares outstanding of redeemable ordinary shares | ||||||||
| Basic and diluted net income per share, redeemable ordinary shares | $ | $ | ||||||
| Weighted average shares outstanding of non-redeemable ordinary shares | ||||||||
| Basic and diluted net loss per share, non-redeemable ordinary shares | ( | ) | ( | ) | ||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| F-2 |
ALPHATIME ACQUISITION CORP
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY/(DEFICIT)
(UNAUDITED)
For the three months ended March 31, 2026
| Shares | Amount | Additional paid-in capital | Accumulated deficit | Total shareholders’ deficit | ||||||||||||||||
| Balance as of December 31, 2025 | $ | $ | - | $ | ( | ) | $ | ( | ) | |||||||||||
| Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) and deposit | - | - | - | ( | ) | ( | ) | |||||||||||||
| Net loss | - | - | - | ( | ) | ( | ) | |||||||||||||
| Balance as of March 31, 2026 | $ | $ | - | $ | ( | ) | $ | ( | ) | |||||||||||
For the three months ended March 31, 2025
| Shares | Amount | Additional paid-in capital | Accumulated deficit | Total shareholders’ deficit | ||||||||||||||||
| Balance as of December 31, 2024 | $ | $ | - | $ | ( | ) | $ | ( | ) | |||||||||||
| Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) and deposit | - | - | - | ( | ) | ( | ) | |||||||||||||
| Net income | - | - | - | |||||||||||||||||
| Net income (loss) | - | - | - | |||||||||||||||||
| Balance as of March 31, 2025 | $ | $ | - | $ | ( | ) | $ | ( | ) | |||||||||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| F-3 |
ALPHATIME ACQUISITION CORP
CONDENSED STATEMENTS OF CASH FLOWS
For the three months ended March 31, 2026 and 2025 (Unaudited)
| 2026 | 2025 | |||||||
| Three months ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| Cash Flows from Operating Activities: | ||||||||
| Net income (loss) | $ | ( | ) | $ | ||||
| Adjustments to reconcile net income to net cash used in operating activities: | ||||||||
| Income earned on Trust Account | ( | ) | ( | ) | ||||
| Changes in current assets and liabilities: | ||||||||
| Prepaid expenses | ( | ) | ( | ) | ||||
| Accounts payable and accrued expenses | ||||||||
| Due to HCYC | ||||||||
| Due to related parties | ||||||||
| Net cash provided by operating activities | $ | - | $ | |||||
| Cash Flows from Investing Activities: | ||||||||
| Principal deposited in Trust Account | $ | - | $ | ( | ) | |||
| Cash withdrawn from Trust Account in connection with redemption | - | |||||||
| Net cash provided by (used in) investing activities | $ | $ | ( | ) | ||||
| Cash Flows from Financing Activities: | ||||||||
| Redemption of ordinary shares | ( | ) | - | |||||
| Net cash (used in) provided by financing activities | $ | ( | ) | $ | - | |||
| Net change in cash | - | ( | ) | |||||
| Cash—beginning of the period | ||||||||
| Cash—end of the period | $ | $ | ||||||
| Supplemental disclosure of noncash financing activities: | ||||||||
| Remeasurement adjustment on ordinary shares subject to possible redemption | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed financial statements.
| F-4 |
ALPHATIME ACQUISITION CORP
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Note 1 — Description of Organization, Business Operations and Liquidity
AlphaTime
Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on
As of March 31, 2026, the Company had not commenced any operations. All activity for the period from September 15, 2021 (inception) through March 31, 2026 relates to the Company’s organizational activities, those necessary to prepare for and complete the initial public offering (“IPO”), identifying a target company for a Business Combination, and activities in connection with the proposed Business Combination described below. The Company will not generate any operating revenues until the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of income earned on the proceeds held in the Trust Account (as defined below). The Company has selected December 31 as its fiscal year end.
The
Company’s sponsor is Alphamade Holding LP, a Delaware limited partnership (the “Sponsor”). The registration statement
for the Company’s IPO was declared effective on December 30, 2022. On January 4, 2023, the Company consummated the IPO of
Simultaneously
with the closing of the IPO, the Company completed the sale of
Following
the closing of the IPO and the sale of over-allotment Units, an aggregate of $
The Company initially had 9 months (or up to 18 months, if we extend the time to complete a business combination) from January 4, 2023, the closing of the Initial Public Offering to consummate a Business Combination (the “Combination Period”).
| F-5 |
Proposed Business Combination
On January 5, 2024, the Company entered into an Agreement and Plan of Merger (as amended, the “Merger Agreement”) by and among the Company, HCYC Holding Company (“PubCo”), ATMC Merger Sub 1 Limited, ATMC Merger Sub 2 Limited, HCYC Merger Sub Limited, and HCYC Group Company Limited, a Cayman Islands exempted company (“HCYC”), providing for a business combination by means of a series of mergers among the Company, the merger subsidiaries and HCYC. On November 12, 2025, the registration statement on Form F-4 relating to the proposed business combination with HCYC was declared effective by the SEC.
On
December 5, 2025, the Company held an extraordinary general meeting of shareholders (the “BC Meeting”) at which the Company’s
shareholders approved the Merger Agreement and the transactions contemplated thereunder. In connection with the BC Meeting, shareholders
holding an aggregate of
Extensions and Redemptions
The Company has extended the date by which it must complete an initial Business Combination on a number of occasions through amendments to its governing documents and the Investment Management Trust Agreement, dated as of December 30, 2022, with Equiniti Trust Company, LLC (as amended, the “Trust Agreement”), funded by deposits into the Trust Account in exchange for non-interest bearing, unsecured promissory notes payable upon the consummation of a Business Combination.
On
September 27, 2023, the Company extended the time to complete its initial business combination from October 4, 2023 to January 4, 2024
by depositing an aggregate of $
At
an extraordinary general meeting of shareholders held on December 28, 2023 (the “Meeting”), the Company adopted the Company’s
Third Amended and Restated Memorandum and Articles of Association (the “Third Amended and Restated Memorandum and Articles of Association”)
reflecting the extension of the date by which the Company must consummate a business combination from January 4, 2024 (the “Termination
Date”) up to ten (10) times, the first extension comprised of three months, and the subsequent nine (9) extensions comprised of
one month each (each an “Extension”) up to January 4, 2025 (i.e., for a period of time ending up to 24 months after the consummation
of its Initial Public Offering for a total of twelve (12) months after the Termination Date (assuming a business combination has not
occurred). The Company also entered into an amendment (the “Trust Agreement Amendment”) to the Investment Management Trust
Agreement, dated as of December 30, 2022, with Equiniti Trust Company, LLC (as amended, the “Trust Agreement”). Pursuant
to the Trust Agreement Amendment, the Company has extended the date by which it has to complete a business combination from the Termination
Date up to ten (10) times, with the first extension comprised of three months, and the subsequent nine (9) extensions comprised of one
month each from the Termination Date, or extended date, as applicable, to January 4, 2025 by providing five days’ advance notice
to the trustee prior to the applicable Termination Date, or extended date, and depositing into the Trust Account $
In
connection with the shareholders’ vote at the meeting on December 28, 2023,
| F-6 |
At
an extraordinary general meeting of shareholders held on December 20, 2024 (the “Second Meeting”), the Company adopted an
amendment to the Third Amended and Restated Memorandum and Articles of Association (the “Amendment”) reflecting the extension
of the date by which the Company must consummate a business combination from January 4, 2025 (the “Termination Date”) up
to nine (9) times, each comprised of one month each (each an “Extension”) up to October 4, 2025 (i.e., for a period of time
ending up to 33 months after the consummation of its Initial Public Offering for a total of nine (9) months after the Termination Date
(assuming a business combination has not occurred). The Company also entered into an amendment (the “Second Trust Agreement Amendment”)
to the Trust Agreement. Pursuant to the Second Trust Agreement Amendment, the Company has extended the date by which it has to complete
a business combination from the Termination Date up to nine (9) times, each comprised of one month each from the Termination Date, or
extended date, as applicable, to October 4, 2025 by providing five days’ advance notice to the trustee prior to the applicable
Termination Date, or extended date, and depositing into the Trust Account an Extension Payment of $
In
connection with the shareholders’ vote at the Second Meeting, holders of
On
October 1, 2025, the Company held an extraordinary general meeting (the “Third Meeting”), solely with respect to voting on
(i) the proposal to extend the date by which the Company must complete its initial business combination from October 4, 2025 to January
4, 2026, with all three (3) extensions comprised of one month each and (ii) the proposal to amend the Company’s investment management
trust agreement, dated as of December 30, 2022, by and between the Company and Equiniti Trust Company, LLC to allow the Company to extend
the Termination Date up to three (3) times, with each extension comprised of one month each from the Termination Date, or extended date,
as applicable, to January 4, 2026, by providing five days’ advance notice to the trustee prior to the applicable Termination Date,
or extended date, and depositing into the trust account $
In
connection with the shareholders’ vote at the Third Meeting, holders
of
On
December 16, 2025, the Company held an extraordinary general meeting (the “Fourth Meeting”), solely with respect to voting
on (i) the proposal to extend the date by which the Company must complete its initial business combination from January 4, 2026 to April
4, 2026, with all three (3) extensions comprised of one month each and (ii) the proposal to amend the Company’s investment management
trust agreement, dated as of December 30, 2022, by and between the Company and Equiniti Trust Company, LLC to allow the Company to extend
the Termination Date up to three (3) times, with each extension comprised of one month each from the Termination Date, or extended date,
as applicable, to April 4, 2026, by providing five days’ advance notice to the trustee prior to the applicable Termination Date,
or extended date, and depositing into the trust account $
In
connection with the shareholders’ vote at the Fourth Meeting, holders
of
| F-7 |
On
March 27, 2026, the Company held an extraordinary general meeting (the “Fifth Meeting”), solely with respect to voting on
(i) the proposal to extend the date by which the Company must complete its initial business combination from April 4, 2026 to December
4, 2026, with all eight (8) extensions comprised of one month each and (ii) the proposal to amend the Company’s investment management
trust agreement, dated as of December 30, 2022, by and between the Company and Equiniti Trust Company, LLC to allow the Company to extend
the Termination Date up to eight (8) times, with each extension comprised of one month each from the Termination Date, or extended date,
as applicable, to December 4, 2026, by providing five days’ advance notice to the trustee prior to the applicable Termination Date,
or extended date, and depositing into the trust account $
In
connection with the shareholders’ vote at the Fifth Meeting, holders of
On
January 4, 2024, the Company deposited $
Nasdaq Delisting
On January 8, 2026, The Nasdaq Stock Market LLC (“Nasdaq”) notified the Company that on January 13, 2026, it would announce that it will delist the Company’s ordinary shares, warrants, rights and units as a result of the Company exceeding the maximum three-year period permitted for a special purpose acquisition company to complete an initial business combination following its initial public offering. Trading in the Company’s securities was suspended on January 7, 2026, and the Company’s securities have not traded on Nasdaq since December 9, 2025. On January 15, 2026, Nasdaq filed a Form 25 with the SEC to remove the Company’s ordinary shares, rights, units and warrants from listing on Nasdaq and to withdraw the registration of such securities under Section 12(b) of the Exchange Act. The delisting became effective ten days after the Form 25 was filed, and the withdrawal of registration under Section 12(b) became effective 90 days after the Form 25 was filed. As of the date of this report, the Company’s securities are not listed on any national securities exchange.
Liquidity and Going Concern
As
of March 31, 2026, the Company had $
In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company’s working capital deficit and the mandatory liquidation and subsequent dissolution that would be required should the Company be unable to complete a Business Combination within the applicable period raise substantial doubt about the Company’s ability to continue as a going concern. In response to these conditions, management has adopted plans intended to address the substantial doubt about the Company’s ability to continue as a going concern. Management intends to continue to pursue the consummation of the Business Combination with HCYC. Prior to the consummation of a Business Combination, the Company intends to cover any working capital shortfalls through extension loans and other financing arrangements. In addition, the Company is seeking alternative ways to complete the Business Combination, including applying to have the Company’s securities quoted on the OTC market, in order to maintain the Company’s public trading status and facilitate the completion of the Business Combination. Notwithstanding these plans, management cannot conclude that it is probable that its plans will be effectively implemented within one year after the date that the unaudited condensed financial statements are available to be issued, or that, if implemented, the plans will mitigate the conditions and events that raise substantial doubt about the Company’s ability to continue as a going concern. Accordingly, management has concluded that its plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Note 2 — Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods presented. Operating results for the three months ended March 31, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2026 or any future period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and the related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
| F-8 |
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Accordingly, actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had a cash and cash equivalents balance of $
Investment Held in Trust Account
The Company’s portfolio of investments held in the Trust Account is comprised of investments in U.S. government securities, generally having a readily determinable fair value. Gains and losses resulting from the change in fair value of these securities and income earned on the investments held in the Trust Account are included in income earned on the Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Ordinary Shares Subject to Possible Redemption
The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing
Liabilities from Equity.” Ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and
measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either
within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s
control) are classified as temporary equity. The Company’s ordinary shares feature certain redemption rights that are considered
to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2026
and December 31, 2025,
| F-9 |
At March 31, 2026, the ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:
Schedule of Subject to Possible Redemption
| Ordinary shares subject to possible redemption at December 31, 2025 | $ | |||
| Redemption of ordinary shares | ( | ) | ||
| Subsequent measurement of ordinary shares subject to possible redemption | ||||
| Ordinary shares subject to possible redemption at March 31, 2026 | $ |
Net Income (Loss) Per Share
The Company complies with the accounting and disclosure requirements of FASB ASC 260, “Earnings Per Share.” Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period, allocated between the redeemable ordinary shares and the non-redeemable ordinary shares using the two-class method. Remeasurement of the carrying value of ordinary shares subject to possible redemption to redemption value is treated as a deemed dividend to the redeemable shareholders. As of March 31, 2026, the Company did not have any dilutive securities that could potentially be exercised or converted into ordinary shares. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the periods presented.
The following table presents the calculation of basic and diluted net income (loss) per share:
Schedule of Net Income (Loss) Per Share
For the three months ended March 31, 2026 | For the three months ended March 31, 2025 | |||||||
| Net income (loss) | $ | ( | ) | $ | ||||
| Income earned on Trust Account | ( | ) | ( | ) | ||||
| Accretion of carrying value to redemption value | - | ( | ) | |||||
| Net loss including accretion of equity into redemption value | $ | ( | ) | $ | ( | ) | ||
Schedule of Income (Loss) Basic and Diluted Per Share
| Redeemable | Non- Redeemable | Redeemable | Non- Redeemable | |||||||||||||
Three months ended March 31, 2026 | Three months ended March 31, 2025 | |||||||||||||||
| Redeemable | Non- Redeemable | Redeemable | Non- Redeemable | |||||||||||||
| Particulars | Shares | Shares | Shares | Shares | ||||||||||||
| Basic and diluted net income/(loss) per share: | ||||||||||||||||
| Numerators: | ||||||||||||||||
| Allocation of net loss including accretion of temporary equity | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Income earned on Trust Account | — | — | ||||||||||||||
| Accretion of temporary equity to redemption value | — | — | — | |||||||||||||
| Allocation of net income/(loss) | $ | $ | ( | ) | $ | $ | ( | ) | ||||||||
| Denominators: | ||||||||||||||||
| Weighted-average shares outstanding | ||||||||||||||||
| Basic and diluted net income/(loss) per share | $ | $ | ( | ) | $ | $ | ( | ) | ||||||||
| F-10 |
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. As of March 31, 2026 and December 31, 2025, there were no unrecognized tax benefits and no amounts accrued for interest and penalties.
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
Note 3 — Initial Public Offering
Pursuant
to the IPO, the Company sold
Note 4 — Private Placement
Simultaneously
with the closing of the IPO, the Sponsor purchased an aggregate of
Note 5 — Related Party Transactions
Founder Shares
On
September 28, 2021, the Sponsor purchased
Promissory Notes — Related Party
The
Company has issued a series of unsecured promissory notes to the Sponsor to finance working capital and costs associated with extending
the period available to complete a Business Combination. The notes are non-interest bearing and are payable upon the consummation of
a Business Combination. As of March 31, 2026 and December 31, 2025, the aggregate amount outstanding under the promissory notes issued
to the Sponsor was $
Due to Related Parties
From
time to time, the Sponsor and the Company’s officers and directors advance funds to the Company, or pay expenses on behalf of the
Company, for working capital purposes. As of March 31, 2026 and December 31, 2025, the amount due to related parties was $
Administrative Support Agreement
Commencing
on the effective date of the IPO, the Company agreed to pay an affiliate of the Sponsor a total of $
| F-11 |
Note 6 — Commitments and Contingencies
Registration Rights
The holders of the Founder Shares, Private Units (and underlying securities) and any units that may be issued upon conversion of working capital loans are entitled to registration rights pursuant to a registration rights agreement. These holders are entitled to make up to a specified number of demands that the Company register such securities and to certain “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The
underwriters were paid an underwriting discount of $
Due to HCYC
HCYC,
the Company’s proposed business combination target, has from time to time paid certain expenses on behalf of the Company. As of
March 31, 2026 and December 31, 2025, the amount due to HCYC was $
Note 7 — Shareholders’ Deficit
Preferred
Shares — The Company is authorized to issue
Ordinary
Shares — The Company is authorized to issue
Warrants
— Each Warrant entitles the holder to purchase one Ordinary Share at a price of $
Note 8 — Fair Value Measurements
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. The Company’s investments held in the Trust Account are classified within Level 1 of the fair value hierarchy because they are valued using quoted prices in active markets for identical assets. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis and indicates the fair value hierarchy of the valuation inputs utilized:
Schedule of Fair Value Assets Measured on Recurring Basis
| March 31, 2026 | December 31, 2025 | |||||||||
| Investments held in Trust Account | Level 1 | $ | $ | |||||||
Note 9 — Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the unaudited condensed financial statements were available to be issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment to or disclosure in the unaudited condensed financial statements, other than as described below.
At
the Fifth Meeting held on March 27, 2026,
In
April 2026, the Company paid $
Subsequent
to March 31, 2026, the target company, HCYC, paid certain additional operating costs on behalf of the Company amounting to $
| F-12 |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and our audited financial statements and the related notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements. Because we are a blank check company, the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, may not be available to us. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results expressed or implied by these forward-looking statements. Except as required by applicable law, we do not undertake any obligation to update or revise any forward-looking statements.
Overview
We are a blank check company incorporated in the Cayman Islands on September 15, 2021 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”). We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.
Our registration statement for our initial public offering (the “Initial Public Offering”) was declared effective on December 30, 2022. On January 4, 2023, we consummated the Initial Public Offering of 6,000,000 units (the “Units”), at $10.00 per Unit, generating gross proceeds of $60,000,000. On January 9, 2023, the underwriters exercised their over-allotment option in full, resulting in the sale of an additional 900,000 Units at $10.00 per Unit, generating additional gross proceeds of $9,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 370,500 private placement units (the “Private Placement Units”) at $10.00 per unit, generating gross proceeds of $3,705,000, and, on January 9, 2023, simultaneously with the sale of the over-allotment Units, we consummated the sale of an additional 38,700 Private Placement Units, generating additional gross proceeds of $387,000. A total of $70,242,000 (or $10.18 per Unit sold in the Initial Public Offering) was placed in the trust account (the “Trust Account”).
On March 27, 2026, we held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) to approve, among other things, the Extension Amendment Proposal and the Trust Agreement Amendment Proposal. In connection with the vote to approve the Extension Amendment Proposal and the Trust Agreement Amendment Proposal, the holders of 6,135 ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately $12.99 per share. The aggregate redemption amount of approximately $79,701.15 was paid in April 2026, subsequent to the end of the quarter. Separately, in January 2026, 69 ordinary shares tendered in connection with the Fourth Meeting were redeemed for $889.39 (approximately $12.89 per share).
As of March 31, 2026, we had not commenced any operations. All activity through March 31, 2026 relates to our formation and the Initial Public Offering and, since the closing of the Initial Public Offering, the search for a prospective initial Business Combination and activities in connection with the proposed Business Combination with HCYC. On January 5, 2024, we entered into the Merger Agreement with HCYC, and on December 5, 2025, our shareholders approved the Merger Agreement at the BC Meeting. The Business Combination has not been consummated as of the date of this report. The PIPE Financing of $11.5 million is expected to close substantially concurrently with, and is conditioned on, the closing of the Business Combination. Our securities were delisted from Nasdaq following the Form 25 filed on January 15, 2026. We do not expect to generate any operating revenues until after the completion of our initial Business Combination, at the earliest. We generate non-operating income in the form of income earned on investments held in the Trust Account.
| 1 |
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception through March 31, 2026 were organizational activities, those necessary to prepare for the Initial Public Offering and, since the Initial Public Offering, the identification and evaluation of a prospective target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.
For the three months ended March 31, 2026, we had a net loss of $159,875, which consisted of formation and operating costs of $202,143, partially offset by income earned on the Trust Account of $42,268.
For the three months ended March 31, 2025, we had net income of $117,969, which consisted of income earned on the Trust Account of $301,371, partially offset by formation and operating costs of $183,402.
Income earned on the Trust Account decreased from $301,371 for the three months ended March 31, 2025 to $42,268 for the three months ended March 31, 2026, primarily due to the lower balance held in the Trust Account following redemptions in connection with prior extension meetings, and changes in prevailing interest rates. Formation and operating costs increased from $183,402 to $202,143.
Liquidity and Capital Resources
As of March 31, 2026, we had cash of $1,233 held outside of the Trust Account and a working capital deficit of $4,491,174. As of March 31, 2026, we had investments held in the Trust Account of $4,841,963. Income earned on the Trust Account may be used by us to pay taxes. Through March 31, 2026, we have not withdrawn any income earned on the Trust Account to pay our tax obligations.
Funds held in the Trust Account are subject to the redemption rights of our public shareholders and are not available to fund our working capital. Of the Trust Account balance at March 31, 2026, $79,701.15 was paid in April 2026 to holders who redeemed in connection with the Fifth Meeting, and holders of 382,091 ordinary shares have elected to redeem in connection with the Business Combination, which redemptions will become effective only upon closing. In addition, $565,144 of extension payments had not been deposited into the Trust Account as of March 31, 2026. As a result, the funds that may be available from the Trust Account upon closing of the Business Combination are expected to be substantially less than the Trust Account balance. Subject to the foregoing, we intend to use the funds held in the Trust Account remaining after redemptions, including any amounts representing income earned on the Trust Account (less amounts released to pay taxes), to complete our initial Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies. We have limited liquidity. As of March 31, 2026, we had only $1,233 of unrestricted cash and a working capital deficit of $4,491,174, and we have relied on advances from our Sponsor, our officers and directors and HCYC to fund operating expenses. None of these parties is obligated to provide further funding. Completion of the Business Combination is also dependent on the PIPE Financing, which is conditioned on the closing.
In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. As of March 31, 2026, there was $1,262,500 outstanding under promissory notes payable to a related party and $766,690 outstanding under amounts borrowed from HCYC.
Going Concern
In connection with our assessment of going concern considerations in accordance with Accounting Standards Update 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution, together with the Company’s working capital deficit, raise substantial doubt about the Company’s ability to continue as a going concern. In response to these conditions, management has adopted plans intended to address the substantial doubt about the Company’s ability to continue as a going concern. Management intends to continue to pursue the consummation of the Business Combination with HCYC. Prior to the consummation of a Business Combination, the Company intends to cover any working capital shortfalls through extension loans and other financing arrangements. In addition, the Company is seeking alternative ways to complete the Business Combination, including applying to have the Company’s securities quoted on the OTC market, in order to maintain the Company’s public trading status and facilitate the completion of the Business Combination. Notwithstanding these plans, management cannot conclude that it is probable that its plans will be effectively implemented within one year after the date that the unaudited condensed financial statements are available to be issued, or that, if implemented, the plans will mitigate the conditions and events that raise substantial doubt about the Company’s ability to continue as a going concern. Accordingly, management has concluded that its plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after the relevant date by which it must complete a Business Combination.
In addition, because the required extension payments were not deposited in full, there is uncertainty as to whether the extensions were validly effected and as to the date by which we are required to complete a Business Combination, which could require us to redeem our public shares and wind up earlier than anticipated.
Off-Balance Sheet Arrangements
We did not have any off-balance sheet arrangements as of March 31, 2026.
| 2 |
Contractual Obligations
As of March 31, 2026, we did not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than the deferred underwriting commission of $2,415,000 payable to the underwriters of our Initial Public Offering upon the completion of our initial Business Combination, and an agreement to pay an affiliate of our Sponsor a monthly fee for office space, secretarial and administrative support services.
Critical Accounting Estimates
The preparation of these unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting estimates:
Ordinary Shares Subject to Possible Redemption. We account for our ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. We recognize changes in redemption value immediately as they occur and adjust the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period.
Net Income (Loss) per Ordinary Share. We comply with the accounting and disclosure requirements of ASC Topic 260, “Earnings Per Share.” Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the periods. We apply the two-class method in calculating earnings per share, allocating net income (loss) between the redeemable ordinary shares and the non-redeemable ordinary shares.
Recent Accounting Pronouncements
Our management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our unaudited condensed financial statements.
Emerging Growth Company Status
We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and we have elected to take advantage of the benefits of the extended transition period for complying with new or revised accounting standards. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. We are also a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.
| 3 |
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
As required by Rule 13a-15(b) and Rule 15d-15(b) under the Exchange Act, our management, including our Chief Executive Officer and Chief Financial Officer, evaluated, as of March 31, 2026, the effectiveness of our disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e) and Rule 15d-15(e). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of March 31, 2026, due to the material weakness in our internal control over financial reporting related to insufficient review of related party transactions, as described in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2025. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our unaudited condensed financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report present fairly in all material respects our financial position, results of operations and cash flows for the periods presented.
Management intends to continue to implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting. Specifically, we intend to expand and improve our review process for related party transactions and ensure that communication with related parties is sufficient to ensure completeness of related party transactions. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.
We believe, however, that a controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls systems are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, within a company have been detected.
Changes in Internal Control over Financial Reporting
Other than the remediation efforts implemented during the quarter described above, there were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
| 4 |
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
To the knowledge of our management, there is no material litigation, arbitration, bankruptcy, receivership, governmental proceeding or other proceeding currently pending against us or any members of our management team in their capacity as such.
Item 1A. Risk Factors
As of the date of this Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on November 10, 2026.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Use of Proceeds
On January 4, 2023, the Company consummated the initial public offering of 6,000,000 Units (the “Units” and, with respect to the Ordinary shares included in the Units sold, the “Public Shares”), and an additional 900,000 Units issued on January 9, 2023 pursuant to the underwriters’ exercise in full of their over-allotment option, at $10.00 per Unit, generating aggregate gross proceeds of $69,000,000.
Simultaneously with the closing of the initial public offering, we consummated the sale of 370,500 Private Placement Units at a price of $10.00 per Private Placement Unit, generating gross proceeds of $3,705,000. On January 9, 2023, simultaneously with the sale of the over-allotment Units, the Company consummated the private sale of an additional 38,700 Private Placement Units, generating additional gross proceeds of $387,000.
Transaction costs related to the issuances described above amounted to $4,892,699 consisting of $1,612,500 of underwriting fees, $2,415,000 of deferred underwriting fees and $865,199 of other offering costs. Following the closing of the initial public offering and the sale of the Private Placement Units, an aggregate of $70,242,000 (or $10.18 per share sold in the initial public offering) was placed in the Trust Account.
Redemptions
On March 27, 2026, the Company held the Extraordinary General Meeting to vote on the Extension Amendment Proposal and the Trust Agreement Amendment Proposal. In connection with the vote to approve the Extension Amendment Proposal and the Trust Agreement Amendment Proposal, the holders of 6,135 Ordinary Shares properly exercised their rights to redeem their shares for cash at a redemption price of approximately $12.99 per share. The aggregate redemption amount of approximately $79,701.15 was paid in April 2026, subsequent to the end of the quarter. During the quarter ended March 31, 2026, the Company redeemed 69 Ordinary Shares in January 2026 for an aggregate of $889.39 (approximately $12.89 per share) in connection with the Fourth Meeting.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
| 5 |
Item 6. Exhibits
EXHIBIT INDEX
| Exhibit Number | Description | |
| 3.1 | Form of Amendment to Third Amended and Restated Memorandum and Articles of Association, adopted on March 27, 2026. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on April 2, 2026). | |
| 10.1 | Amendment to the Investment Management Trust Agreement, dated March 27, 2026, by and between AlphaTime Acquisition Corp and Equiniti Trust Company, LLC. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on April 2, 2026). | |
| 31.1* | Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a). | |
| 31.2* | Certification of Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a). | |
| 32.1** | Certification of Principal Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350. | |
| 32.2** | Certification of Principal Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350. | |
| 101.INS | Inline XBRL Instance Document | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema | |
| 101.CAL | Inline XBRL Taxonomy Calculation Linkbase | |
| 101.LAB | Inline XBRL Taxonomy Label Linkbase | |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
| 101.DEF | Inline XBRL Definition Linkbase Document | |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
*Filed herewith.
**Furnished herewith.
| 6 |
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.
November 12, 2026
| ALPHATIME ACQUISITION CORP | ||
| By: | /s/ Gan Kim Hai | |
| Gan Kim Hai | ||
| Chief Executive Officer (Principal Executive Officer) | ||
| By: | /s/ Gan Kim Hai | |
Yingxuan Shan Chief Financial Officer (Principal Financial and Accounting Officer) |
| 7 |